SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-032902
Filing Date
2023-03-15
Accepted
2023-03-15 17:31:01
Documents
6
Effectiveness Date
2023-03-15

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm239371d1_s8.htm S-8 33050
2 EXHIBIT 5.1 tm239371d1_ex5-1.htm EX-5.1 9738
3 EXHIBIT 23.1 tm239371d1_ex23-1.htm EX-23.1 2399
4 EX-FILING FEES tm239371d1_ex-fillingfees.htm EX-FILING FEES 13121
5 GRAPHIC image_001.jpg GRAPHIC 2935
6 GRAPHIC image_002.jpg GRAPHIC 1661
  Complete submission text file 0001104659-23-032902.txt   65998
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270585 | Film No.: 23736343
SIC: 2834 Pharmaceutical Preparations